To verify the role of CXCR4 and CD133 in ovarian cancer patients, CXCR4, CD133, CD44, CD24 were evaluated in 37 surgically resected primary ovarian epithelial tumors (Table 2). Here, PROM1 is linked to ovarian carcinoma.